Early Diagnostic Markers and Therapeutic Targets for Experimental Breast Cancer
Bulletin of Experimental Biology and Medicine(2022)
摘要
Various stem cells were studied in female BALB/c mice at the early terms after administration of N-methyl-N-nitrosourea to search early diagnostic markers and therapeutic targets. At these terms, damage to the epithelium and endothelium, inflammation, and fibrosis were observed in the mammary gland, but the tumor was not detected. Cancer stem cells, hematopoietic stem cells (HSC), hematopoietic progenitor cells, angiogenic precursors, and epithelial progenitor cells were found in the blood and mammary gland. Cancer stem cells (CD44 + CD24 — ) are proposed as the early diagnostic marker of breast cancer, and short-living HSC, hematopoietic progenitor cells, and angiogenic precursors (CD45—CD117 + FLK-1 + ) as predictors of the formation of tumor microenvironment.
更多查看译文
关键词
breast cancer, stem cells, early diagnosis and treatment, diagnostic markers, therapeutic targets
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要